Cibc World Market Inc. Bristol Myers Squibb CO Transaction History

Cibc World Market Inc.

$43.4 Billion
Q2 2024

A detailed history of Cibc World Market Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cibc World Market Inc. holds 256,569 shares of BMY stock, worth $12.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

256,569

Previous 375,963 31.76%

Holding current value

$12.8 Million

Previous $20.4 Million 47.74%

% of portfolio

0.02%

Previous 0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$40.25 - $52.99 $4.81 Million - $6.33 Million	-119,394 Reduced 31.76%	256,569 $10.7 Million
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $9.83 Million - $11.1 Million	204,960 Added 119.86%	375,963 $20.4 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $2.22 Million - $2.65 Million	-45,766 Reduced 21.11%	171,003 $8.77 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $1.54 Million - $1.72 Million	-26,557 Reduced 10.91%	216,769 $12.6 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $6.45 Million - $7.16 Million	101,216 Added 71.22%	243,326 $15.6 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $779,911 - $884,596	-11,869 Reduced 7.71%	142,110 $9.85 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $79,231 - $93,821	-1,157 Reduced 0.75%	153,979 $11.1 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $3,895 - $2.3 Million	-29,962 Reduced 16.19%	155,136 $11 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $1.2 Million - $1.33 Million	16,580 Added 9.84%	185,098 $14.3 Million
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $7.05 Million - $8.45 Million	-114,638 Reduced 40.49%	168,518 $12.3 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $774,846 - $903,288	14,448 Added 5.38%	283,156 $17.7 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $3.49 Million - $4.09 Million	-58,952 Reduced 17.99%	268,708 $15.9 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $836,342 - $910,776	13,509 Added 4.3%	327,660 $21.9 Million
Q1 2021 May 11, 2021	SELL	$59.34 - $66.74 $951,635 - $1.07 Million	-16,037 Reduced 4.86%	314,151 $19.8 Million
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $654,136 - $741,256	-11,329 Reduced 3.32%	330,188 $20.5 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $1.73 Million - $1.92 Million	30,189 Added 9.7%	341,517 $20.6 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $711,070 - $831,311	-12,971 Reduced 4.0%	311,328 $18.3 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $1.62 Million - $2.36 Million	-34,989 Reduced 9.74%	324,299 $18.1 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $6.66 Million - $8.68 Million	135,297 Added 60.4%	359,288 $23.1 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $2.28 Million - $2.7 Million	53,205 Added 31.15%	223,991 $11.4 Million
Q2 2019 Aug 08, 2019	SELL	$44.62 - $49.34 $3.92 Million - $4.34 Million	-87,921 Reduced 33.98%	170,786 $7.75 Million
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $1.22 Million - $1.46 Million	-27,074 Reduced 9.47%	258,707 $12.3 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $5.54 Million - $7.19 Million	-113,688 Reduced 28.46%	285,781 $14.9 Million
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $49.5 Million - $55.8 Million	-896,900 Reduced 69.19%	399,469 $24.8 Million
Q2 2018 Aug 08, 2018	BUY	$50.53 - $62.98 $51.4 Million - $64 Million	1,016,753 Added 363.62%	1,296,369 $71.7 Million
Q1 2018 May 18, 2018	SELL	$59.92 - $68.98 $2.21 Million - $2.55 Million	-36,917 Reduced 11.66%	279,616 $17.7 Million
Q4 2017 Feb 01, 2018	BUY	$59.94 - $65.35 $1.21 Million - $1.32 Million	20,192 Added 6.81%	316,533 $19.4 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $16.4 Million - $18.9 Million	296,341	296,341 $18.9 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $106B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account

Cibc World Market Inc. Bristol Myers Squibb CO Transaction History